Patrick Stone

FDA investigator

Appears on 5 documents from 2002 to 2015, mostly at sites in Texas. Most often cites circumstances in which IRB review is required (21 CFR 56.103).

5
Documents on file
4.0
Observations per 483
2002
First seen
2015
Most recent

What they cite most

From 8 observations

Activity by year

2002: 1, 2006: 1, 2010: 1, 2011: 1, 2015: 1

Is Patrick Stone coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Burzynski Research Institute/ IRBJul 17, 2015 · Houston, Texas
Warning letter Cetero ResearchJul 26, 2011 · Houston, Texas
483 Cetero ResearchMay 7, 2010 · Houston, Texas
Warning letter MD Anderson Cancer CenterMay 15, 2006 · Houston, Texas
Warning letter Burzynski Research InstituteApr 29, 2002 · Houston, Texas

About this profile

What does Patrick Stone inspect?

Patrick Stone appears on 5 documents on file covering 2 sites, mostly in Texas.

What do they cite most often?

21 CFR 56.103 (circumstances in which IRB review is required), followed by 21 CFR 56.108(a) and 21 CFR 56.109.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Patrick Stone is dated Jul 17, 2015.